News
Latest news from CHV and our portfolio companies
Featured News
January 20, 2026, Boston, MA: Catalyst Health Ventures (CHV), a venture capital firm focused on advancing transformative medical technologies, today announced the promotion of David Mackey to Partner. Mackey has…
Insights & Impacts: The latest from CHV
Data to be presented on February 3rd during a Spotlight Session at AF Symposium 2023
Novel Foam-Based Design Demonstrates Successful LAAO Seal with No Device-Related Thrombus Conformal Medical, Inc., a
Rejoni announced today that it has closed a $25 million Series B financing. The round
– Clinical and economic benefits of the PreTRM® test and treat strategy illustrated amongst diverse
AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular
Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health
Seasoned Medical Device Executive, James Reinstein, Appointed as Chief Executive Officer Conformal Medical, Inc., a
– Grant Supports Continued Clinical Development of the Company’s PTM-101 Product and its Potential for
BEDFORD, Mass., – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral
Study to support U.S. FDA approval of the novel CLAASâ implant for left atrial appendage